Green Cross Corporation (006280) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Green Cross Corporation (006280:KRX), powered by AI.

Current Price
₩131,100
P/E Ratio
-327.8
Market Cap
1.5T
Sector
Healthcare
What is the Green Cross Corporation stock price forecast?

Green Cross Corporation is currently trading at ₩131,100. View real-time AI analysis on Alpha Lenz.

What is Green Cross Corporation insider trading activity?

View the latest insider trading data for Green Cross Corporation on Alpha Lenz.

What is Green Cross Corporation's P/E ratio?

Green Cross Corporation's P/E ratio is -327.8.

Green Cross Corporation

KRX · 006280
₩131,100+1,100(+0.85%)Market closedKRX regular session 09:00–15:30 KST
Ask about Green Cross Corporation's future dividend policy...
Alpha Chat Insight

Green Cross Corporation trades at a P/E of -327.8 (undervalued) with modest ROE of -0.4%.

Ask for details

Company Overview

Green Cross Corporation is a prominent pharmaceutical company based in South Korea, primarily focused on developing and manufacturing therapeutic biologics and vaccines. With a strong emphasis on biotechnology, the company produces a wide array of products including blood derivatives, vaccines for various infectious diseases, and plasma-based therapies. Green Cross Corporation plays a pivotal role in the healthcare industry, both domestically and internationally, by contributing to public health initiatives and vaccine distribution efforts. As a leader in the biotechnology sector, the company is committed to research and development, driving innovations that enhance treatment options and improve patient outcomes. In the financial market, Green Cross Corporation holds significance as a key player in the pharmaceutical industry, influencing health-focused investment strategies and offering insights into biotechnological advancements. Founded with the mission of improving health and extending life, Green Cross continues to strengthen its market presence through strategic partnerships and a robust pipeline of new products, positioning itself as a critical contributor to global healthcare solutions.

CEO허은철
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees2,009

Company Statistics

FY 2025

Profile

₩1,532,105,131,800Market Cap
₩1,991,279,093,820Revenue
11.69MShares Out
2,009Employees

Margins

27.83%Gross
10.69%EBITDA
3.47%Operating
-1.77%Pre-Tax
-1.49%Net

Valuation

-327.80P/E
1.26P/B
0.77EV/Sales
12.41EV/EBITDA
-263.44P/FCF

Growth (CAGR)

5.18%Rev 3Yr
5.77%Rev 5Yr
-5.24%Op Inc 3Yr
6.58%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-1.04%ROA
-0.38%ROE
0.52%ROIC

Financial Health

₩49,372,311,050Cash & Cash Equivalents
₩1,527,450,129,670Net Debt
113.09%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Green Cross Corporation (ticker: 006280) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 2,009 employees. Market cap is $1.5T.

The current price is ₩131,100 with a P/E ratio of -327.8x and P/B of 1.26x.

ROE is -0.38% and operating margin is 3.47%. Annual revenue is $2.0T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Green Cross Corporation (006280) Stock Forecast 2026 ₩131,100 — Price, Financials & Analyst Targets | Alpha Lenz